open access

Vol 15, No 2 (2022)
Guidelines / Expert consensus
Get Citation

Principles of management in patients with autosomal dominant polycystic kidney disease (ADPKD), who are candidates for kidney and/or liver transplantation — recommendations of PTT Working Group, part I

Alicja Dębska-Ślizień1, Roman Danelewicz2, Magdalena Jankowska1, Hanna Suchanek3, Maciej Kosieradzki2, Marcin Matuszewski4
DOI: 10.5603/RDTF.2022.0008
·
Renal Disease and Transplantation Forum 2022;15(2):95-109.
Affiliations
  1. Department of Nephrology, Transplantology and Internal Medicine, Medical Faculty, Medical University of Gdańsk
  2. Department of General and Transplant Surgery, Medical Faculty, Medical University of Warsaw, University Clinical Center of the Medical University of Warsaw
  3. Department of Internal Medicine, Connective Tissue Disease and Geriatrics, University Clinical Center in Gdańsk
  4. Department of Urology, Medical Faculty, Medical University of Gdańsk

open access

Vol 15, No 2 (2022)
Recommendations, Standards and Opinions

Abstract

These guidelines address the management of patients with autosomal dominant polycystic kidney disease who are candidates for kidney and/or liver transplantation. They include issues such as enlisting for transplantation, indications for nephrectomy, indications for simultaneous kidney and liver transplantation, qualification of a living donor, and qualification for renal replacement therapy in a patient with a failing transplanted kidney.

Abstract

These guidelines address the management of patients with autosomal dominant polycystic kidney disease who are candidates for kidney and/or liver transplantation. They include issues such as enlisting for transplantation, indications for nephrectomy, indications for simultaneous kidney and liver transplantation, qualification of a living donor, and qualification for renal replacement therapy in a patient with a failing transplanted kidney.

Get Citation

Keywords

polycystic kidney disease, polycystic liver disease, chronic kidney disease, transplantation, dialysis

About this article
Title

Principles of management in patients with autosomal dominant polycystic kidney disease (ADPKD), who are candidates for kidney and/or liver transplantation — recommendations of PTT Working Group, part I

Journal

Renal Disease and Transplantation Forum

Issue

Vol 15, No 2 (2022)

Article type

Guidelines / Expert consensus

Pages

95-109

Page views

309

Article views/downloads

48

DOI

10.5603/RDTF.2022.0008

Bibliographic record

Renal Disease and Transplantation Forum 2022;15(2):95-109.

Keywords

polycystic kidney disease
polycystic liver disease
chronic kidney disease
transplantation
dialysis

Authors

Alicja Dębska-Ślizień
Roman Danelewicz
Magdalena Jankowska
Hanna Suchanek
Maciej Kosieradzki
Marcin Matuszewski

References (73)
  1. Jankowska M, Kuźmiuk-Glembin I, Skonieczny P, et al. Native nephrectomy in renal transplant recipients with autosomal dominant polycystic kidney disease. Transplant Proc. 2018; 50(6): 1863–1867.
  2. Kanaan N, Devuyst O, Pirson Y. Renal transplantation in autosomal dominant polycystic kidney disease. Nat Rev Nephrol. 2014; 10(8): 455–465.
  3. Rozanski J, Kozlowska I, Myslak M, et al. Pretransplant nephrectomy in patients with autosomal dominant polycystic kidney disease. Transplant Proc. 2005; 37(2): 666–668.
  4. Messa P, Alfieri CM, Montanari E, et al. ADPKD: clinical issues before and after renal transplantation. J Nephrol. 2016; 29(6): 755–763.
  5. Cornec-Le Gall E, Audrézet MP, Rousseau A, et al. The PROPKD score: a new algorithm to predict renal survival in autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 2016; 27(3): 942–951.
  6. Müller RU, Messchendorp AL, Birn H, et al. An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease International. Nephrol Dial Transplant. 2022; 37(5): 825–839.
  7. Dębska-Ślizień A, Jankowska M, Nowicki M, et al. Polish Society of neprology working Group – Management of autosomal polycystic kidney disease (ADPKD) and other cystic kidney diseases [in polish]. Nefrol Dial Pol. 2019; 23: 1–15.
  8. Banach-Ambroziak E, Jankowska M, Grzywińska M, et al. Application of total kidney volume and its predictive value in assessment of kidney transplant waitlist candidates with autosomal dominant polycystic kidney disease. Transplant Proc. 2020; 52(8): 2273–2277.
  9. Chadban SJ, Ahn C, Axelrod DA, et al. Summary of the kidney disease: improving global outcomes (KDIGO) clinical practice guideline on the evaluation and management of candidates for kidney transplantation. Transplantation. 2020; 104(4): 708–714.
  10. Skauby MH, Øyen O, Hartman A, et al. Kidney transplantation with and without simultaneous bilateral native nephrectomy in patients with polycystic kidney disease: a comparative retrospective study. Transplantation. 2012; 94(4): 383–388.
  11. Neeff HP, Pisarski P, Tittelbach-Helmrich D, et al. One hundred consecutive kidney transplantations with simultaneous ipsilateral nephrectomy in patients with autosomal dominant polycystic kidney disease. Nephrol Dial Transplant. 2013; 28(2): 466–471.
  12. Argyrou C, Moris D, Vernadakis S. Tailoring the 'perfect fit' for renal transplant recipients with end-stage polycystic kidney disease: indications and timing of native nephrectomy. In Vivo. 2017; 31(3): 307–312.
  13. Jänigen BM, Hempel J, Holzner P, et al. Simultaneous ipsilateral nephrectomy during kidney transplantation in autosomal dominant polycystic kidney disease: a matched pair analysis of 193 consecutive cases. Langenbecks Arch Surg. 2020; 405(6): 833–842.
  14. Vanderlinde ES, Heal JM, Blumberg N. Autologous transfusion. BMJ. 2002; 324(7340): 772–775.
  15. Chebib FT, Prieto M, Jung Y, et al. Native nephrectomy in renal transplant recipients with autosomal dominant polycystic kidney disease. Transplant Direct. 2015; 1(10): e43.
  16. Jankowska M, Kuźmiuk-Glembin I, Skonieczny P, et al. Native nephrectomy in renal transplant recipients with autosomal dominant polycystic kidney disease. Transplant Proc. 2018; 50(6): 1863–1867.
  17. Obwieszczenie Ministra Zdrowia z dnia 6 marca 2019 r. w sprawie wymagań dobrej praktyki pobierania krwi i jej składników, badania, preparatyki, przechowywania, wydawania i transportu dla jednostek organizacyjnych publicznej służby krwi. Dziennik Urzędowy Ministra Zdrowia. Warszawa, dnia 7 marca 2019 r., poz. 25. http://dziennikmz.mz.gov.pl/legalact/2019/25/ (12.03.2022).
  18. Eckardt KU, Möllmann M, Neumann R, et al. Erythropoietin in polycystic kidneys. J Clin Invest. 1989; 84(4): 1160–1166.
  19. Kanaan N, Devuyst O, Pirson Y. Renal transplantation in autosomal dominant polycystic kidney disease. Nat Rev Nephrol. 2014; 10(8): 455–465.
  20. Domen RE. Adverse reactions associated with autologous blood transfusion: evaluation and incidence at a large academic hospital. Transfusion. 1998; 38(3): 296–300.
  21. Patel MS, Kandula P, Wojciechowski D, et al. Trends in the management and outcomes of kidney transplantation for autosomal dominant polycystic kidney disease. J Transplant. 2014; 2014: 675697.
  22. Bretagnol A, Büchler M, Boutin JM, et al. [Renal transplantation in patients with autosomal dominant polycystic kidney disease: pre-transplantation evaluation and follow-up]. Nephrol Ther. 2007; 3(7): 449–455.
  23. Fuller TF, Brennan TV, Feng S, et al. End stage polycystic kidney disease: indications and timing of native nephrectomy relative to kidney transplantation. J Urol. 2005; 174(6): 2284–2288.
  24. Brazda E, Ofner D, Riedmann B, et al. The effect of nephrectomy on the outcome of renal transplantation in patients with polycystic kidney disease. Ann Transplant. 1996; 1(2): 15–18.
  25. Maxeiner A, Bichmann A, Oberländer N, et al. Native nephrectomy before and after renal transplantation in patients with autosomal dominant polycystic kidney disease (ADPKD). J Clin Med. 2019; 8(10): 1622.
  26. Grodstein EI, Baggett N, Wayne S, et al. An evaluation of the safety and efficacy of simultaneous bilateral nephrectomy and renal transplantation for polycystic kidney disease: a 20-year experience. Transplantation. 2017; 101(11): 2774–2779.
  27. Knispel HH, Klän R, Offermann G, et al. Transplantation in autosomal dominant polycystic kidney disease without nephrectomy. Urol Int. 1996; 56(2): 75–78.
  28. Illesy L, Kovács DÁ, Szabó RP, et al. Autosomal dominant polycystic kidney disease transplant recipients after kidney transplantation: a single-center experience. Transplant Proc. 2017; 49(7): 1522–1525.
  29. Veroux M, Zerbo D, Basile G, et al. Simultaneous native nephrectomy and kidney transplantation in patients with autosomal dominant polycystic kidney disease. PLoS One. 2016; 11(6): e0155481.
  30. Jänigen BM, Hempel J, Holzner P, et al. Simultaneous ipsilateral nephrectomy during kidney transplantation in autosomal dominant polycystic kidney disease: a matched pair analysis of 193 consecutive cases. Langenbecks Arch Surg. 2020; 405(6): 833–842.
  31. Lucas SM, Mofunanya TC, Goggins WC, et al. Staged nephrectomy versus bilateral laparoscopic nephrectomy in patients with autosomal dominant polycystic kidney disease. J Urol. 2010; 184(5): 2054–2059.
  32. Sulikowski T, Tejchman K, Zietek Z, et al. Experience with autosomal dominant polycystic kidney disease in patients before and after renal transplantation: a 7-year observation. Transplant Proc. 2009; 41(1): 177–180.
  33. Rozanski J, Kozlowska I, Myslak M, et al. Pretransplant nephrectomy in patients with autosomal dominant polycystic kidney disease. Transplant Proc. 2005; 37(2): 666–668.
  34. Dunn MD, Portis AJ, Elbahnasy AM, et al. Laparoscopic nephrectomy in patients with end-stage renal disease and autosomal dominant polycystic kidney disease. Am J Kidney Dis. 2000; 35(4): 720–725.
  35. Desai MR, Nandkishore SK, Ganpule A, et al. Pretransplant laparoscopic nephrectomy in adult polycystic kidney disease: a single centre experience. BJU Int. 2008; 101(1): 94–97.
  36. Chen K, Tan YuG, Tan D, et al. Predictors and outcomes of laparoscopic nephrectomy in autosomal dominant polycystic kidney disease. Investig Clin Urol. 2018; 59(4): 238–245.
  37. Pfister D, Thüer D, Heidenreich A. [Pitfalls and outcome of nephrectomy for patients with polycystic kidney disease: Peri- and postoperative results]. Urologe A. 2010; 49(9): 1156, 1158–62.
  38. Desai PJ, Castle EP, Daley SM, et al. Bilateral laparoscopic nephrectomy for significantly enlarged polycystic kidneys: a technique to optimize outcome in the largest of specimens. BJU Int. 2008; 101(8): 1019–1023.
  39. Król R, Ziaja J, Cierniak T, et al. Simultaneous transabdominal bilateral nephrectomy in potential kidney transplant recipients. Transplant Proc. 2006; 38(1): 28–30.
  40. Martin AD, Mekeel KL, Castle EP, et al. Laparoscopic bilateral native nephrectomies with simultaneous kidney transplantation. BJU Int. 2012; 110(11 Pt C): E1003–E1007.
  41. Kramer A, Sausville J, Haririan A, et al. Simultaneous bilateral native nephrectomy and living donor renal transplantation are successful for polycystic kidney disease: the University of Maryland experience. J Urol. 2009; 181(2): 724–728.
  42. Ismail HR, Flechner SM, Kaouk JH, et al. Simultaneous vs. sequential laparoscopic bilateral native nephrectomy and renal transplantation. Transplantation. 2005; 80(8): 1124–1127.
  43. Tyson MD, Wisenbaugh ES, Castle EP, et al. Simultaneous kidney transplantation and bilateral native nephrectomy for polycystic kidney disease. J Urol. 2013; 190(6): 2170–2174.
  44. Ahmad SB, Inouye B, Phelan MS, et al. Live donor renal transplant with simultaneous bilateral nephrectomy for autosomal dominant polycystic kidney disease is feasible and satisfactory at long-term follow-up. Transplantation. 2016; 100(2): 407–415.
  45. Saljoghi R, Le Vourch A, Renard B, et al. [Arterial embolization of polycystic kidneys as an alternative to ergonomic nephrectomy in renal pre-transplantation. Monocentric retrospective study]. Prog Urol. 2019; 29(10): 482–489.
  46. Petitpierre F, Cornelis F, Couzi L, et al. Embolization of renal arteries before transplantation in patients with polycystic kidney disease: a single institution long-term experience. Eur Radiol. 2015; 25(11): 3263–3271.
  47. Pierre M, Moreau K, Braconnier A, et al. Unilateral nephrectomy versus renal arterial embolization and technique survival in peritoneal dialysis patients with autosomal dominant polycystic kidney disease. Nephrol Dial Transplant. 2020; 35(2): 320–327.
  48. Ye W, Voss MD, Athreya S. Volume reduction in enlarged kidneys in autosomal dominant polycystic kidney disease (ADPKD) prior to renal transplant with transcatheter arterial embolization (TAE): a systematic review and meta-analysis. Cardiovasc Intervent Radiol. 2018; 41(6): 828–834.
  49. Wetzel O, Hormi M, Le Normand L, et al. [Autosomal dominant polycystic kidney disease: urologic complications and results of kidney transplantation: 217 patients]. Prog Urol. 1993; 3(2): 252–262.
  50. Schoots IG, Zaccai K, Hunink MG, et al. Bosniak classification for complex renal cysts reevaluated: a systematic review. J Urol. 2017; 198(1): 12–21.
  51. Smith AD, Allen BC, Sanyal R, et al. Outcomes and complications related to the management of Bosniak cystic renal lesions. AJR Am J Roentgenol. 2015; 204(5): W550–W556.
  52. Mousessian PN, Yamauchi FI, Mussi TC, et al. Malignancy rate, histologic grade, and progression of bosniak category III and IV complex renal cystic lesions. AJR Am J Roentgenol. 2017; 209(6): 1285–1290.
  53. Hindman NM. Cystic renal masses. Abdom Radiol (NY). 2016; 41(6): 1020–1034.
  54. Chapman AB, Devuyst O, Eckardt KU, et al. Conference Participants. Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2015; 88(1): 17–27.
  55. Bae KT, Zhu F, Chapman AB, et al. Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP). Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohort. Clin J Am Soc Nephrol. 2006; 1(1): 64–69.
  56. Hogan MC, Abebe K, Torres VE, et al. Liver involvement in early autosomal-dominant polycystic kidney disease. Clin Gastroenterol Hepatol. 2015; 13(1): 155–164.e6.
  57. Gevers TJG, Hol JC, Monshouwer R, et al. Effect of lanreotide on polycystic liver and kidneys in autosomal dominant polycystic kidney disease: an observational trial. Liver Int. 2015; 35(5): 1607–1614.
  58. Pisani A, Sabbatini M, Imbriaco M, et al. ALADIN Study Group. Long-term effects of octreotide on liver volume in patients with polycystic kidney and liver disease. Clin Gastroenterol Hepatol. 2016; 14(7): 1022–1030.e4.
  59. Qian Qi, Du H, King B, et al. Sirolimus reduces polycystic liver volume in ADPKD patients. J Am Soc Nephrol. 2008; 19(3): 631–638.
  60. van Aerts RMM, van de Laarschot LFM, Banales JM, et al. Clinical management of polycystic liver disease. J Hepatol. 2018; 68(4): 827–837.
  61. Dios-Barbeito S, Domínguez-Bastante M, Moreno-Navas A, et al. Multicentric study of the andalusian experience in polycystic liver disease as indication for liver transplantation. Transplant Proc. 2018; 50(2): 613–616.
  62. Gedaly R, Guidry P, Davenport D, et al. Peri-operative challenges and long-term outcomes in liver transplantation for polycystic liver disease. HPB (Oxford). 2013; 15(4): 302–306.
  63. van Keimpema L, Nevens F, Adam R, et al. European Liver and Intestine Transplant Association. Excellent survival after liver transplantation for isolated polycystic liver disease: an European Liver Transplant Registry study. Transpl Int. 2011; 24(12): 1239–1245.
  64. Durazo FA, Tong MJ. Unusual indications for transplantation. In: Busuttil R, Klintmalm G. ed. Transplantation of the Liver. 3rd Edition. Elsevier/Saunders, Philadelphia 2015.
  65. Ruiz R, Klintmalm G. Combined liver-kidney transplantation. In: Busuttil R, Klintmalm G. ed. Transplantation of the Liver. 3rd Edition. Elsevier/Saunders, Philadelphia 2015.
  66. Ding F, Tang H, Zhao H, et al. Long-term results of liver transplantation for polycystic liver disease: Single-center experience in China. Exp Ther Med. 2019; 17(5): 4183–4189.
  67. Bari K, Sharma P. Optimizing the selection of patients for simultaneous liver-kidney transplant. Clin Liver Dis. 2021; 25(1): 89–102.
  68. Alsager M, Neong SF, Gandhi R, et al. Liver transplantation in adult polycystic liver disease: the Ontario experience. BMC Gastroenterol. 2021; 21(1): 115.
  69. Miles CD, Westphal S, Liapakis A, et al. Simultaneous liver-kidney transplantation: impact on liver transplant patients and the kidney transplant waiting list. Curr Transplant Rep. 2018; 5(1): 1–6.
  70. O'Leary JG, Gebel HM, Ruiz R, et al. Class II alloantibody and mortality in simultaneous liver-kidney transplantation. Am J Transplant. 2013; 13(4): 954–960.
  71. Das A, Taner T, Kim J, et al. Crossmatch, donor-specific antibody testing, and immunosuppression in simultaneous liver and kidney transplantation: a review. Transplantation. 2021; 105(12): e285–e291.
  72. Coquillard C, Berger J, Daily M, et al. Combined liver-kidney transplantation for polycystic liver and kidney disease: analysis from the United Network for Organ Sharing dataset. Liver Int. 2016; 36(7): 1018–1025.
  73. Fong TL, Khemichian S, Shah T, et al. Combined liver-kidney transplantation is preferable to liver transplant alone for cirrhotic patients with renal failure. Transplantation. 2012; 94(4): 411–416.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.